Protein may indicate atherosclerosis risk in patients with psoriatic disease

The presence of cardiac troponin I may indicate a risk for atherosclerosis in patients with psoriatic disease independently from traditional cardiovascular risk factors, according to data published in Arthritis and Rheumatology.
“While findings from general population cohort studies indicate that cardiac high-sensitivity troponin I (cTnI) and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) are strong predictors of CV risk, limited information exists in patients with rheumatic diseases and particularly in those with [psoriatic disease (PsD)],” Keith Colaço, MSc, of the Women’s

The presence of cardiac troponin I may indicate a risk for atherosclerosis in patients with psoriatic disease independently from traditional cardiovascular risk factors, according to data published in Arthritis and Rheumatology.
“While findings from general population cohort studies indicate that cardiac high-sensitivity troponin I (cTnI) and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) are strong predictors of CV risk, limited information exists in patients with rheumatic diseases and particularly in those with [psoriatic disease (PsD)],” Keith Colaço, MSc, of the Women’s